Category: <span>Mesothelioma treatment</span>

Category: Mesothelioma treatment

cancer treatments, IMPRINT for mesothelioma, lung cancer treatments, Mesothelioma News, Mesothelioma treatment, pleural mesothelioma, radiation for mesothelioma, radiation therapy

IMPRINT Mesothelioma Treatment Boosts Radiation Therapy

 

Doctors confirmed a novel radiation procedure can be combined safely and effectively with aggressive lung-sparing surgery to improve survival time and quality of life for patients with mesothelioma. After a decade of refinement, a small number of mesothelioma specialty centers now are using intensity-modulated pleural radiation therapy (IMPRINT) as part of the recent advancements in…

The post IMPRINT Mesothelioma Treatment Boosts Radiation Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer treatments, IMPRINT for mesothelioma, lung cancer treatments, Mesothelioma News, Mesothelioma treatment, pleural mesothelioma, radiation for mesothelioma, radiation therapy

IMPRINT Mesothelioma Treatment Boosts Radiation Therapy

 

Doctors confirmed a novel radiation procedure can be combined safely and effectively with aggressive lung-sparing surgery to improve survival time and quality of life for patients with mesothelioma. After a decade of refinement, a small number of mesothelioma specialty centers now are using intensity-modulated pleural radiation therapy (IMPRINT) as part of the recent advancements in…

The post IMPRINT Mesothelioma Treatment Boosts Radiation Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

clinical trial, Immunotherapy, immunotherapy clinical trial, immunotherapy for mesothelioma, Mesothelioma News, Mesothelioma Research, Mesothelioma treatment, raffitt hassan

Immunotherapy Trial for Mesothelioma Shows Early Promise

 

The immunotherapy drug avelumab showed promising results in a recent phase I clinical trial for malignant mesothelioma, raising hopes as a future second-line therapy. The clinical trial included 53 patients with pleural or peritoneal mesothelioma. It was part of the JAVELIN development program for avelumab, a series of clinical studies testing the drug on about…

The post Immunotherapy Trial for Mesothelioma Shows Early Promise appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer surgery, cancer treatment, mesothelioma, Mesothelioma News, mesothelioma surgery, Mesothelioma treatment, Wickii Vigneswaran

Mesothelioma Surgery Improves Quality of Life

 

Renowned thoracic surgeon Dr. Wickii Vigneswaran in Chicago believes far too many patients with pleural mesothelioma are being denied aggressive surgeries that could improve their quality of life. He wants to fix that dilemma. Vigneswaran, a mesothelioma specialist at the Loyola University Medical Center, authored a recent study debunking the long-standing belief that major surgery…

The post Mesothelioma Surgery Improves Quality of Life appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

mesothelioma, Mesothelioma News, mesothelioma surgery, Mesothelioma treatment, new mesothelioma study, peritoneal mesothelioma, treatment for peritoneal mesothelioma

Peritoneal Mesothelioma: No End in Sight

 

Marty Kanarek has spent the last 40 years as an environmental epidemiologist trying to make the world a safer place to live. Asbestos — and its sordid history — has made that task considerably harder. “[Asbestos] is still the most frightening thing in environmental epidemiology,” Kanarek, professor of population health sciences and environmental studies at…

The post Peritoneal Mesothelioma: No End in Sight appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Alternative Mesothelioma Treatments, Bradford Institute of Cancer Therapeutics, British Lung Foundation, HRX9, Ian Jarrold, Malignant mesothelioma, Mesothelioma News, Mesothelioma treatment, Professor Richard Morgan, University of Bradford, University of Surry

New Study Finds A Potential New Mesothelioma Gene-targeting Drug

 

A study for a new drug called HRX9 shows it can stop tumor growth and trigger cell death in mesothelioma—for the first time ever.

decortication, Dr. Giovanni Leuzzi, EPP, Extrapleural pneumonectomy, malignant pleural mesothelioma, Mesothelioma News, Mesothelioma treatment, Pleurectomy, Regina Elena National Cancer Institute

New Statistical Model To Identify Ideal Mesothelioma Patients For Surgery

 

A doctor from Regina Elena National Cancer Institute has developed a new statistical model to help identify which mesothelioma patients could benefit most from surgery.

Associate Professor Tony George, Australia, mesothelioma cancer, mesothelioma latency period, mesothelioma life expectancy, Mesothelioma News, Mesothelioma treatment, Michael Wallach, SPARK Sydney, University of Technology Sydney

New Mesothelioma Treatment Seems Promising In Pre-Clinical Testing

 

A professor from the University of Technology, Sydney has developed a new treatment for mesothelioma patients, which has shown promising results in its pre-clinical testing.

Bristol-Myers Squibb, Dr. Richard Pazdur, Dr. Roy Herbst, Dr. Scott Gettinger, FDA, Immunotherapy, Keytruda, Merck, mesothelioma, Mesothelioma News, Mesothelioma treatment, Opdivo

Can Opdivo Drug Be Good News for Mesothelioma Patients?

 

Expanded approved use of new lung cancer drug Opdivo could give malignant pleural mesothelioma patients hope.